UMIN-ICDS History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000049016 |
|---|---|
| Receipt number | R000055809 |
| Scientific Title | Randomised Controlled Trial of Meropenem versus Cefmetazole for definitive treatment of bloodstream infections due to ESBL- producing Escherichia coli |
| Date of disclosure of the study information | 2022/09/26 |
| Last modified on | 2023/11/08 12:52:29 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2022/09/26 12:53:39 | ||
| 2 | Update | 2022/09/26 14:56:50 | Institutions |
|
| 3 | Update | 2022/09/27 12:11:54 | Key inclusion criteria Key exclusion criteria |
|
| 4 | Update | 2022/09/27 12:23:37 | Key secondary outcomes |
|
| 5 | Update | 2022/12/08 17:14:47 | UMIN ID1 |
|
| 6 | Update | 2022/12/15 13:57:45 | Recruitment status Date of IRB |
|
| 7 | Update | 2023/03/28 12:56:42 | UMIN ID2 |
|
| 8 | Update | 2023/03/28 13:33:56 | Institutions |
|
| 9 | Update | 2023/08/02 14:10:45 | Institutions |
|
| 10 | Update | 2023/08/29 10:40:39 | Email Name of person sending information Name of person sending information |
|
| 11 | Update | 2023/08/29 10:54:02 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 12 | Update | 2023/09/26 09:30:25 | Recruitment status Other related information Other related information |
|
| 13 | Update | 2023/11/08 12:52:29 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
